Bristol-Myers Squibb Co
NYSE:BMY

Watchlist Manager
Bristol-Myers Squibb Co Logo
Bristol-Myers Squibb Co
NYSE:BMY
Watchlist
Price: 51.415 USD -4.33%
Market Cap: 104.6B USD

Relative Value

The Relative Value of one BMY stock under the Base Case scenario is 69.923 USD. Compared to the current market price of 51.415 USD, Bristol-Myers Squibb Co is Undervalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BMY Relative Value
Base Case
69.923 USD
Undervaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
80
vs Industry
45
Median 3Y
2.5
Median 5Y
2.8
Industry
2.4
Forward
2.3
vs History
vs Industry
36
Median 3Y
13.3
Median 5Y
-12.3
Industry
20.5
Forward
7.8
vs History
82
vs Industry
42
Median 3Y
8.1
Median 5Y
8.7
Industry
15.4
vs History
77
vs Industry
33
Median 3Y
10.3
Median 5Y
9.6
Industry
22.8
vs History
7
vs Industry
9
Median 3Y
4.5
Median 5Y
3.8
Industry
1.9
vs History
82
vs Industry
35
Median 3Y
3.2
Median 5Y
3.4
Industry
2.5
Forward
3.1
vs History
76
vs Industry
45
Median 3Y
4.2
Median 5Y
4.4
Industry
4.9
vs History
73
vs Industry
39
Median 3Y
7.1
Median 5Y
7.4
Industry
12.4
Forward
8
vs History
80
vs Industry
31
Median 3Y
13.6
Median 5Y
13.9
Industry
15.5
Forward
8.6
vs History
77
vs Industry
37
Median 3Y
10.3
Median 5Y
10.5
Industry
14
vs History
77
vs Industry
30
Median 3Y
11.1
Median 5Y
11.3
Industry
17.9
vs History
31
vs Industry
34
Median 3Y
1.9
Median 5Y
1.7
Industry
1.8

Multiples Across Competitors

BMY Competitors Multiples
Bristol-Myers Squibb Co Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Bristol-Myers Squibb Co
NYSE:BMY
107.8B USD 2.1 -11.5 6.8 12.5
US
Eli Lilly and Co
NYSE:LLY
714.2B USD 15.9 67.4 39.3 43.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
363.4B USD 4.1 25.8 12.1 15.9
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK 6.5 18.8 12.4 14.1
CH
Roche Holding AG
SIX:ROG
196B CHF 3.3 17.1 9.6 11.4
US
Merck & Co Inc
NYSE:MRK
207.4B USD 3.2 12.1 8.2 9.7
CH
Novartis AG
SIX:NOVN
174.8B CHF 3.9 17.1 10.4 13.3
UK
AstraZeneca PLC
LSE:AZN
158.6B GBP 3.8 28.9 125.6 191.8
IE
Endo International PLC
LSE:0Y5F
162.4B USD 70 -55.5 259.5 650.8
US
Pfizer Inc
NYSE:PFE
127.4B USD 2 15.9 7.9 11.2
P/E Multiple
Earnings Growth PEG
US
Bristol-Myers Squibb Co
NYSE:BMY
Average P/E: 25.4
Negative Multiple: -11.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
67.4
49%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
25.8
26%
1
DK
Novo Nordisk A/S
CSE:NOVO B
18.8
19%
1
CH
Roche Holding AG
SIX:ROG
17.1
16%
1.1
US
Merck & Co Inc
NYSE:MRK
12.1
18%
0.7
CH
Novartis AG
SIX:NOVN
17.1
16%
1.1
UK
AstraZeneca PLC
LSE:AZN
28.9
36%
0.8
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -55.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
15.9
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Bristol-Myers Squibb Co
NYSE:BMY
Average EV/EBITDA: 394.4
6.8
-8%
N/A
US
Eli Lilly and Co
NYSE:LLY
39.3
30%
1.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.1
7%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
12.4
15%
0.8
CH
Roche Holding AG
SIX:ROG
9.6
8%
1.2
US
Merck & Co Inc
NYSE:MRK
8.2
9%
0.9
CH
Novartis AG
SIX:NOVN
10.4
5%
2.1
UK
AstraZeneca PLC
LSE:AZN
125.6
9%
14
IE
E
Endo International PLC
LSE:0Y5F
259.5
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.9
3%
2.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Bristol-Myers Squibb Co
NYSE:BMY
Average EV/EBIT: 1 697.9
12.5
11%
1.1
US
Eli Lilly and Co
NYSE:LLY
43.4
33%
1.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
15.9
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
14.1
16%
0.9
CH
Roche Holding AG
SIX:ROG
11.4
9%
1.3
US
Merck & Co Inc
NYSE:MRK
9.7
12%
0.8
CH
Novartis AG
SIX:NOVN
13.3
8%
1.7
UK
AstraZeneca PLC
LSE:AZN
191.8
21%
9.1
IE
E
Endo International PLC
LSE:0Y5F
650.8
N/A N/A
US
Pfizer Inc
NYSE:PFE
11.2
10%
1.1